Classifying the adverse mitogenic mode of action of insulin analogues using a novel mechanism-based genetically engineered human breast cancer cell panel

TitleClassifying the adverse mitogenic mode of action of insulin analogues using a novel mechanism-based genetically engineered human breast cancer cell panel
Publication TypeJournal Article
Year of Publication2014
Authorster Braak, B., Siezen C.L.E., Kannegieter N., Koedoot E., van de Water B., van der Laan J.W.
JournalArchives of Toxicology
Volume88
Pagination953 - 966
Date Published4/2014
ISSN0340-5761
DOI10.1007/s00204-014-1201-2
Short TitleArch Toxicol
DOI10.1007/s00204-014-1201-2
16/06/2014